Cargando…
Real‐time longitudinal analysis of human gliomas reveals in vivo genome evolution and therapeutic impact under standardized treatment
Autores principales: | Xu, Sensen, Sheng, Zhiyuan, Yu, Jinliang, Deng, Kaiyuan, Wu, Shuang, Bu, Yage, Guo, Guangzhong, Zhang, Ziyue, Liu, Guanzheng, Gao, Yushuai, Yan, Zhaoyue, Bu, Chaojie, He, Yingkun, Liu, Gang, Zemmar, Ajmal, Hernesniemi, Juha, Kong, Lingfei, Wang, Meiyun, Li, Tianxiao, Bu, Xingyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9269997/ https://www.ncbi.nlm.nih.gov/pubmed/35802830 http://dx.doi.org/10.1002/ctm2.956 |
Ejemplares similares
-
Tumor DNA From Tumor In Situ Fluid Reveals Mutation Landscape of Minimal Residual Disease After Glioma Surgery and Risk of Early Recurrence
por: Yu, Jinliang, et al.
Publicado: (2021) -
Molecular and clonal evolution in vivo reveal a common pathway of distant relapse gliomas
por: Liu, Guanzheng, et al.
Publicado: (2023) -
Integrating real‐time in vivo tumour genomes for longitudinal analysis and management of glioma recurrence
por: Sheng, Zhiyuan, et al.
Publicado: (2021) -
Tracking tumor evolution during the first-line treatment in brain glioma via serial profiling of cell-free tumor DNA from tumor in situ fluid
por: Sheng, Zhiyuan, et al.
Publicado: (2023) -
Genomic alterations of oligodendrogliomas at distant recurrence
por: Liu, Guanzheng, et al.
Publicado: (2023)